
Europe’s research labs and pharmaceutical companies are both working to discover new drugs, but often speak different dialects. EU-OPENSCREEN was set up to change this by creating a continent-wide research infrastructure for chemical biology and early drug discovery. Within the EU-funded EU-OPENSCREEN-DRIVE project, one of the most effective tools turned out to be not a new machine or invention, but an office with a deceptively simple name: the Industry Liaison Office.








